Usa India Germany covid-19 vaccine Government Usa India Germany

Pfizer sees Covid-19 as 'durable' revenue stream as profits rise

Reading now: 594
www.livemint.com

Covid-19 vaccine sales which are on track to provide a "durable" revenue stream in the wake of the pandemic.The drugmaker reported a jump in first-quarter profits based on surging revenues, with nearly one-fourth of sales coming from Covid-19 vaccines.With German partner BioNTech, the pharma giant is ramping up vaccine production and now estimates 2021 revenues of $26 billion from the vaccine, up from the $15 billion projected in February.But the surging profits have drawn criticism as governments face pressure to step in to ensure vaccines are provided to underserved countries.Pfizer, which says it is on the cusp of winning US approval for individuals 12 to 15 years old to receive its vaccine, is holding talks with "basically all.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA